These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7118066)

  • 21. L-Leucine prevents ammonia-induced changes in glutamate receptors in the brain and in visual evoked potentials in the rabbit.
    Ferenci P; Pappas CS; Jones EA
    JPEN J Parenter Enteral Nutr; 1984; 8(6):700-4. PubMed ID: 6151602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment.
    Bombardieri G; Gigli GL; Bernardi L; Ferri R; Grassi C; Milani A
    Hepatogastroenterology; 1985 Feb; 32(1):3-7. PubMed ID: 3921445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of hepatic encephalopathy with visual evoked potentials compared with conventional methods.
    Sandford NL; Saul RE
    Hepatology; 1988; 8(5):1094-8. PubMed ID: 3417229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ammonia, octanoate and a mercaptan depress regeneration of normal rat liver after partial hepatectomy.
    Zieve L; Shekleton M; Lyftogt C; Draves K
    Hepatology; 1985; 5(1):28-31. PubMed ID: 3967863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
    Ede RJ; Gove CD; Hughes RD; Marshall W; Williams R
    Clin Sci (Lond); 1987 Mar; 72(3):365-71. PubMed ID: 3028700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmission in hepatic encephalopathy.
    Zeneroli ML; Baraldi M
    Adv Exp Med Biol; 1990; 272():135-48. PubMed ID: 1966505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of ammonia and octanoic acid on liver regeneration in the rat.
    Ellis WR; Chu PK; Murray-Lyon IM
    Clin Sci (Lond); 1979 Jan; 56(1):95-7. PubMed ID: 477188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Bolton RP; Losowsky MS
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():66-73. PubMed ID: 2083938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feeding behavior and ambulatory activity in rats with D-galactosamine-induced hepatic failure.
    Shimomura Y; Saito S; Nagamine T; Shimizu H; Takahashi M; Uehara Y; Sato N; Negishi M; Yamada S; Kobayashi I
    Physiol Behav; 1992 May; 51(5):1029-33. PubMed ID: 1352048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methanethiol metabolism and its role in the pathogenesis of hepatic encephalopathy in rats and dogs.
    Blom HJ; Chamuleau RA; Rothuizen J; Deutz NE; Tangerman A
    Hepatology; 1990 Apr; 11(4):682-9. PubMed ID: 2328960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic failure toxins depress liver regenerative enzymes after periportal injury with allyl alcohol in the rat.
    Zieve L; Anderson WR; LaFontaine D
    J Lab Clin Med; 1988 Jun; 111(6):725-30. PubMed ID: 3373115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials.
    Burke DA; Mitchell KW; al Mardini H; Record CO
    Lancet; 1988 Aug; 2(8609):505-6. PubMed ID: 2900422
    [No Abstract]   [Full Text] [Related]  

  • 34. On octanoic acid-induced hyperventilation--implications for hepatic encephalopathy and Reye's syndrome.
    Mitkov D; Toreva D; Krustev A; Kostadinova I; Jumbasova S
    Res Exp Med (Berl); 1989; 189(5):347-54. PubMed ID: 2813970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transference of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange.
    Ryan CJ; Aslam M; Courtney JM
    Biomater Artif Cells Artif Organs; 1990; 18(4):477-82. PubMed ID: 2285809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gamma-Aminobutyric acid (GABA) and hepatic encephalopathy: testing the validity of electroencephalographic evidence of the GABA hypothesis.
    Myslobodsky MS
    Hepatogastroenterology; 1987 Apr; 34(2):58-64. PubMed ID: 3036678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of brain evoked potentials in the detection of subclinical hepatic encephalopathy in cirrhotics].
    Ryu N; Gao W; Yan M
    No To Shinkei; 1997 Oct; 49(10):887-92. PubMed ID: 9368885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperammonemic coma after hepatectomy in germ-free rats.
    Schalm SW; van der Mey T
    Gastroenterology; 1979 Aug; 77(2):231-4. PubMed ID: 447036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.